Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$154,971,166
+$39,497,722 QoQ
Shares Held
129,204
+2.9% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#302
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $1,455,266,466 across 11 Drug Manufacturers - General names. LLY ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,829,082 | $357,426,219 | |
| 2 | JNJ |
Johnson & Johnson
|
1,198,505 | $304,384,314 | |
| 3 | ABBV |
AbbVie Inc.
|
1,073,381 | $270,105,594 | |
| 4 | AMGN |
Amgen Inc
|
697,030 | $252,408,503 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
129,204 | $154,971,166 | |
| 6 | MRK |
Merck & Co., Inc.
|
517,507 | $66,499,649 | |
| 7 | PFE |
Pfizer Inc
|
906,089 | $21,818,623 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
335,197 | $19,314,051 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154,971,166 | 129,204 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $115,473,444 | 125,546 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $166,042,374 | 154,504 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $109,588,164 | 143,628 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $113,678,859 | 145,830 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $106,563,037 | 129,025 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $97,762,992 | 126,636 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $99,181,868 | 111,951 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $108,919,024 | 120,302 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $87,175,085 | 112,056 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $66,807,878 | 114,609 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $67,237,933 | 125,180 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $60,487,633 | 128,977 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $43,195,711 | 125,781 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $40,572,021 | 110,901 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $35,820,713 | 110,780 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $39,838,140 | 122,870 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $48,764,801 | 170,286 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $48,305,077 | 174,879 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $31,423,493 | 136,003 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $31,832,128 | 138,690 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $21,732,583 | 116,329 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $19,688,938 | 116,613 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $16,812,111 | 113,580 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $19,364,538 | 117,947 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $12,658,616 | 91,253 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||